Five-year mean follow-up of NeoHexa sirolimus eluting coronary stent: A retrospective evaluation of long-term safety and efficacy

Figure 1 Patient disposition. FU: Follow-up.

Figure 2 Site of myocardial infarction. MI: Myocardial infarction; AWMI: Anterior wall myocardial infarction; IWMI: Inferior wall myocardial infarction; LWMI: Lateral wall myocardial infarction; PWMI: Posterior wall myocardial infarction.

Figure 3 Kaplan-Meier curves for cumulative major adverse cardiac event-free survival rate. MACE: Major adverse cardiac event.

Figure 4 Subgroup analysis comparing major adverse cardiac event rates. A: Diabetic vs non-diabetic; B: Acute coronary syndrome vs non-acute coronary syndrome; C: Single vessel vs multivessel disease. MACE: Major adverse cardiac event; ACS: Acute coronary syndrome.